Subject to Inquiry

Subject to Inquiry

THE LATEST ON GOVERNMENT INQUIRIES AND ENFORCEMENT ACTIONS

Government Investigations and White Collar Litigation Group

Emily Erb Kelley

Photo of Emily Erb Kelley Emily uses the skills developed during her clerkship in the Eastern District of Virginia, combined with her experience on Capitol Hill, to serve clients in connection with government investigations and white collar defense.

Subscribe to all posts by Emily Erb Kelley

New DOJ Guidance on Corporate Criminal Enforcement

By George J. Terwilliger III, John Adams, Benjamin A. O'Neil, John S. Moran, Caroline Schmidt Burton and Emily Erb Kelley on Enforcement and Prosecution Policy and Trends
RELATED UPDATE: DOJ Announces “Pilot Program Regarding Compensation Incentives and Clawbacks” with Significant Ramifications for Corporations Facing Criminal Investigations (March 6, 2023) On Sept. 15, 2022, U.S. Deputy Attorney General Lisa Monaco announced important guidance and new actions from the U.S. Department of Justice (DOJ or the Department) on corporate criminal enforcement. Her remarks, delivered… Continue Reading

Elizabeth Holmes of Theranos Found Guilty of Making False Representations to Investors

By John Adams, Michael J. Podberesky, Caroline Schmidt Burton, Elissa Baur, Emily Erb Kelley and McGuireWoods LLP on Fraud, Deception and False Claims
Elizabeth Holmes, founder of Theranos, was convicted of three counts of wire fraud and one count of conspiracy to commit wire fraud. The verdict follows a high-profile, fifteen-week trial in federal court in San Francisco.  Holmes was alleged to have defrauded investors, medical professionals, patients, and the public by exaggerating and making false statements about… Continue Reading

Gleanings From DOJ’s 2021 Healthcare Takedown Announcement

By Emily Erb Kelley, Michael J. Podberesky and McGuireWoods LLP on Compliance
On Sept. 17, the U.S. Department of Justice released the results of its 2021 Healthcare Takedown — an annual announcement aggregating months of investigations and indictments across the country involving fraud in the healthcare and life sciences industries. Read on for details and analysis of criminal charges against 138 defendants, including 42 medical professionals, related… Continue Reading

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree